Market News & Trends
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities
Particle Sciences recently announced it has added a third computational module to its DOSE program. The DOSE program uses a combination of empirical data and…
Thermo Fisher Scientific Uses New Method to Determine Sialic Acids in Glycoproteins
Thermo Fisher Scientific recently announced a new method that uses high-performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) to determine sialic acids in glycoproteins. Application…
Veloxis Pharmaceuticals & Athena Drug Delivery Solutions Announce Partnership
Veloxis Pharmaceuticals and Athena Drug Delivery Solutions recently announced an alliance in which Athena will obtain exclusive rights in certain emerging market territories to manufacture…
12/20/2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in…
Covidien Plans Spin-off of Pharmaceuticals Business
Covidien plc, a leading global provider of healthcare products, recently announced it plans to spin off its pharmaceuticals business into a stand-alone public company. Covidien's…
DSM Signs Capsules Contract With QRxPharma
DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V., recently announced the signing of a manufacturing and supply agreement with QRxPharma, Inc., based…
Enlight Biosciences Forms Lucrative New Partnerships
Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight, AstraZeneca and Novo Nordisk will…
Ezose Sciences Forms New Biomarker Agreement With Merck
Ezose Sciences Inc. recently announced it has entered an agreement with Merck, through a subsidiary, to collaborate on biomarker discovery research in the field of…
ProJect Pharmaceutics Introduces Predictive Formulation Analytics for Optimized Biopharmaceutical Formulations
Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates specifically from their three-dimensional structure,…
Pulmatrix Presents iSPERSE Data for Inhaled Combination Therapies
Pulmatrix recently announced that its iSPERSE inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose blending for an effective therapeutic dose of…
Aptar Pharma's Ophthalmic Dispenser Chosen for Eyecare Product
Aptar Pharma recently announced its innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser (OSD) has found its first application for the treatment of dry eye…
Dendreon Corporation Sells Royalty Rights for $125 Million
Dendreon Corporation recently announced it has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering-Plough Ltd.…
Innovus Completes Reverse Merger Agreement With North Horizon
Innovus Pharmaceuticals, Inc., recently announced that FasTrack Pharmaceuticals, Inc. completed its previously announced merger agreement with North Horizon Inc., subsequent to which FasTrack was acquired…
Pharmacyclics Could Get Almost $1 Billion in Licensing Deal
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, recently announced it has executed an agreement with Pharmacyclics, Inc. to jointly…
12/13/2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide collaboration to jointly develop and…
Abbott Laboratories Spends $400 Million on Development Deal
Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide collaboration to jointly develop and commercialize Reata's portfolio of second-generation oral antioxidant…
12/6/2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical…
Ampio Pharmaceuticals Announces Agreement to Acquire Key Delivery Technology
Ampio Pharmaceuticals, Inc. recently announced it has signed an agreement to acquire certain rights relating to a patented orally disintegrating tablet (ODT) drug delivery technology…
Heparinex Receives $1.6-Million Award to Enable CMC for Proprietary Delivery Technology
Heparinex, LLC recently announced the company has received a $1.6-million fund endowment from the Economic Development Generating Excellence program (EDGE). Heparinex and the University of…
MacroGenics Strikes Deal With Servier, Potentially Worth Up to $450 Million
MacroGenics, Inc. and Servier recently announced they have entered into an option for a license agreement for the development and commercialization of MGA271, MacroGenics' proprietary…
